TREACE MEDICAL CONCEPTS, INC.·4

Jan 23, 9:30 PM ET

Elder Scot Michael 4

Research Summary

AI-generated summary

Updated

Treace Medical (TMCI) Chief Legal Officer Receives 262,500 RSUs

What Happened

  • Scot Michael Elder, Treace Medical's Chief Legal & Compensation Officer and Corporate Secretary, was granted 262,500 restricted stock units (RSUs) on 2026-01-22 (reported 2026-01-23). The grant is recorded at $0 per share (typical for RSU awards). On the same date, 9,451 shares were disposed (withheld) to cover tax liability related to equity compensation; that withholding is recorded at $0 value in the filing.

Key Details

  • Transactions: Grant/Award (code A) — 262,500 RSUs acquired; Tax withholding/payment (code F) — 9,451 shares disposed.
  • Transaction date: January 22, 2026; Form 4 filed January 23, 2026 (timely).
  • Price: $0.00 per share for both entries (RSUs are non-cash awards; withholding is a share-for-tax settlement).
  • Vesting: Footnote F2 states the 262,500 RSUs vest in equal annual installments over 4 years, with first vesting on Jan 22, 2027 and final on Jan 22, 2030, subject to continued service.
  • Footnotes F1 and F3 reference additional restricted stock units (378,970 and 641,470) noted in the filing.
  • No open-market purchase or sale of shares was reported (the disposition was tax withholding, not a market sale).

Context

  • RSUs are compensation awards that convert to shares only as they vest; this grant increases potential future share issuance rather than representing an immediate market purchase or sale. The 9,451-share disposition reflects tax withholding to satisfy tax obligations on the award, a routine administrative action. The filing appears timely (reported the day after the transactions).